A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
Status: ACTIVE_NOT_RECRUITING
Study type: INTERVENTIONAL
Conditions: Solid Tumors Harboring NTRK Fusion
Interventions: DRUG: BAY2757556 (Larotrectinib, Vitrakvi)
Sponsor: Bayer